Evidence map›Paper›PMID 34876015›Full record

ArticleBMC cardiovascular disorders2021

Prognosis in patients with coronary heart disease and breath-holding limitations: a free-breathing cardiac magnetic resonance protocol at 3.0 T.

Keyan Wang, Wenbo Zhang, Shuman Li, Xiaoming Bi, Michaela Schmidt, Jing An, Jie Zheng, Jingliang Cheng

Open access · goldAbstract read
In one paragraph

Article in BMC cardiovascular disorders, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Keyan WangMRI Department, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Wenbo ZhangMRI Department, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Shuman LiMRI Department, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Xiaoming BiSiemens Medical Solulations USA, Inc., Los Angeles, USA.
Michaela SchmidtSiemens Healthcare GmbH, Erlangen, Germany.
Jing AnSiemens Shenzhen Magnetic Resonance Ltd, Shenzhen, China.
Jie ZhengMallinckrodt Institute of Radiology, Washington University in St. Louis, St. Louis, Missouri, USA.
Jingliang ChengMRI Department, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. zdyfymri2008@163.com.ORCID 0000-0001-7682-9366
First Affiliated Hospital of Zhengzhou University · CNSiemens (China) · CNSiemens Healthcare (United States) · USSiemens Healthineers (Germany) · DEWashington University in St. Louis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeConventional cardiac magnetic resonance (CCMR) imaging is usually performed with breath-holding (BH), which is adverse in patients with BH limitations. We explored the ability of a free-breathing CMR (fCMR) protocol to prognosticate in patients with coronary heart diseases (CHD) and limited BH ability.

methodsSixty-seven patients with CHD and limited BH abilities were prospectively enrolled in this study. All patients underwent comprehensive fCMR imaging at 3.0 T. The fCMR protocols included compressed sensing (CS) single-shot cine acceleration imaging, and motion-corrected (MOCO), single-shot late gadolinium enhancement (LGE) imaging. Image quality (IQ) of the cine and LGE images was evaluated based on the 5-point Likert scale. The value of fMRI in providing a prognosis in patients with CHD was assessed. Statistical methods included the T test, Mann-Whitney test, Kappa test, Kaplan-Meier curve, Log-rank test, Cox proportional hazard regression analysis, and receiver operating characteristic curves.

resultsAll IQ scores of the short axis CS-cine and both the short and long axes MOCO LGE images were ≥ 3 points. Over a median follow-up of 31 months (range 3.8-38.2), 25 major adverse cardiovascular events (MACE) occurred. In the univariate analysis, infarction size (IS), left ventricular ejection fraction (LVEF), 3D-Global peak longitudinal strain (3D-GPLS), heart failure classification were significantly associated with MACE. When the significantly univariate MACE predictors, added to the multivariate analysis, which showed IS (HR 1.02; 95% CI 1.00-1.05; p = 0.048) and heart failure with preserved EF (HR 0.20; 95% CI 0.04-0.98; p = 0.048) correlated positively with MACE. The optimal cutoff value for LVEF, 3D-GPLS, and IS in predicting MACE was 34.2%, - 5.7%, and 26.1% respectively, with a sensitivity of 90.5%, 64%, and 96.0% and specificity of 72%, 95.2%, and 85.7% respectively.

conclusionsThe fCMR protocol can be used to make prognostic assessments in patients with CHD and BH limitations by calculating IS and LVEF.

Indexed as

Breath HoldingMagnetic Resonance Imaging, CineAgedContrast MediaCoronary DiseaseFemaleGadolinium DTPAHumansLungMaleMiddle AgedMyocardial InfarctionPredictive Value of TestsPrognosisProspective StudiesStroke VolumeContrast MediaGadolinium DTPACardiac magnetic resonanceCoronary heart diseaseFree-breathingPrognoses

Identifiers

PMID34876015
PMCPMC8650562
OpenAlexW4200317875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.